Ann Eldred
Impact in
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
-
- Psoriasis: Treatment and Pathogenesis
Papers in
- Rheumatology 11
- Spondyloarthritis Studies and Treatments 10
- Rheumatoid Arthritis Research and Therapies 2
-
- Psoriasis: Treatment and Pathogenesis 6
- Co-authors
- Kim Papp (12 shared papers)Ahmed M. Soliman (10 shared papers)Wenjing Lü (6 shared papers)Lisa Barcomb (7 shared papers)Frank Behrens (7 shared papers)Zailong Wang (3 shared papers)Douglas White (5 shared papers)Lars Erik Kristensen (3 shared papers)
- Journals
- Annals of the Rheumatic Diseases (6 papers)Lara D. Veeken (3 papers)RMD Open (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Clinical and Translational Science (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Ann Eldred
19 papers receiving 409 citations
Peers
Comparison fields: 5 of 40
- Rheumatology 207
- Immunology 172
- Hematology 86
- Nephrology 37
- Dermatology 37
Countries citing papers authored by Ann Eldred
This map shows the geographic impact of Ann Eldred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Eldred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Eldred more than expected).
Fields of papers citing papers by Ann Eldred
This network shows the impact of papers produced by Ann Eldred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Eldred. The network helps show where Ann Eldred may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Eldred, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 103 | |
| 2 | 2021 | 81 | |
| 3 | 2018 | 42 | |
| 4 | 1999 | 35 | |
| 5 | 2016 | 30 | |
| 6 | 2022 | 25 | |
| 7 | 2022 | 23 | |
| 8 | Fecal lysozyme: an unreliable marker for colorectal cancer. | 1992 | 14 |
| 9 | 2022 | 12 | |
| 10 | 2017 | 10 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2024 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2022 | 1 | |
| 19 | 2023 | 1 |
About Ann Eldred
Ann Eldred is a scholar working on Rheumatology, Immunology, Molecular Biology, Hematology and Nephrology, having authored 19 papers that have together received 415 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (10 papers), Psoriasis: Treatment and Pathogenesis (6 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Retinoids in leukemia and cellular processes (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Amoebic Infections and Treatments (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Rheumatology (207 citations), Immunology (172 citations), Hematology (86 citations), Nephrology (37 citations) and Dermatology (37 citations). Ann Eldred has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Kim Papp, Ahmed M. Soliman, Wenjing Lü, Lisa Barcomb, Frank Behrens, Zailong Wang, Douglas White, Lars Erik Kristensen, Mauro Waldemar Keiserman and Alan Kivitz. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, Clinical Pharmacology & Therapeutics and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.